| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |